Pfizer Wins Dismissal Of Lipitor Class Action
A proposed class action lawsuit that accused Pfizer Inc. of deceptively marketing its blockbuster cholesterol treatment Lipitor has been dismissed after more than two years of litigation in which the plaintiffs'...To view the full article, register now.
Already a subscriber? Click here to view full article